Takeaways – Asia Pacific Angel Conference

I’ve just completed a two day stint in Singapore attending the inaugural Asia Pacific Angel Investor conference.  The conference has been an eye opening and horizon lifting experience – I’ve been exposed to and reminded of the immense power and potential of global angel networks.  At this conference I met early investors in Expedia, Google, Skype and I’ve connected with professional life science investors.  I’ve listened to investors that have had fantastic successes across India, China, Europe, Australia and the United States; watched a New Zealand company pitch to the group and arguably steal the pitching show.  So what have been the key takeaways?

Networks, networks, networks drive success – the creme de la crème of Asia Pacific Angels presented at the conference.  These guys have portfolios numbering 50+ seed investments (by comparison i’m up to about 17), with what appeared to be about 40% success rates (exits for value) and multiples on many deals exceeding 100x their investment and achieved in about four years – GULP.  OK, they didn’t talk a lot about their failures.  However, what seemed to underpin this success was the way they leveraged their networks to create value in these companies….fast, very fast.  The Angels in these groups are seriously experienced entrepreneurs and business executives who have influence in their industries and geographic regions. We need to connect to and build these networks.

NZ Start-up Inc must drive faster and harder, to be relevant – it’s mind boggling how fast the best companies grow and the results they achieve in these markets.  In NZ we tend to bake, bake and bake and then fire a half-loaded pea shooter at an elephant of a market.  I’m not proposing that we load the gun with lots of cash and rush to markets we don’t understand.  BUT, we definantly need to spend more time and money in these large markets and leverage local talent and local investors to enter these markets.  Our (MOVACs) best performing ventures are the ones spending 50% or more of their time on a plane out of New Zealand.  This costs…

The $3million equity gap is endemic across the world – NZ Inc has a real problem in facilitating later stage investment rounds beyond what’s become the typical NZ$250k – NZ$1m Angel round.  BUT, this problem exists everywhere!  Investors from China, India, Singapore, US, Australia all expressed this problem.  The oxymoron is that Asia is considered to be “awash with cash” particularly China and India.  BUT, this cash is sitting in large funds chasing US$10million+ deals.  So, Angels across the region, are having to dig deep and go further with their investments.  From an NZ Inc perspective, Angel Investor groups will need to seriously consider multiple rounds of investment when pulling together deals; and / or focus on deals with a clear and short path to break-even or sale of the business.  At Movac we’ve adopted the role of thumb that an NZ business with global aspirations will need a minimum of NZ$3 million across it’s lifecycle.

NZ entrepreneurs easily foot it in this crowd – We had 12 or more pitch sessions at the conference.  As a rule “I hate pitch sessions at these conferences cos I attend these conferences to meet other investors and I want to maximize this interaction”. However, it gave me an opportunity to bench-mark the NZ opportunities I’ve seen over the last couple of years versus the “up and comers” from the region and guess what?  We foot it, we foot it real well! NZ Companies with experienced and balanced teams (idea + sales + management + experience) have nothing to fear in terms of their ability to foot it and stand out in this region.

Competition for scarce funding is a great driver for deal quality – I spent some time over dinner talking to a very successful Silicon Valley investor.  His view on the success of Silicon Valley was = great universities, producing exceptional talent chasing an organized but limited community of investors = hot bed of competition for money and a real sense of urgency.  My experience in NZ Inc. is we don’t get this yet – our Universities are geared to creating employees not entrepreneurs.

Cultural sensitivities – Hand over your business cards (and credit cards for that matter) with two-hands and respectively.  Receive the business cards with two hands and inspect it graciously.  Leave you jeans and tee shirt at home (major challenge for me).  Be prepared to pay $15 for a friggin cup of coffee in a hotel (Singapore).  The fundamental difference between eastern and western culture is that the West focuses on the individual the East focus on family and community (at least that’s what one of the presenters who’s been successful in both cultures said).  Most of the successful entrepreneur / investors that presented were AmeriAsians (is that a word?) – Asians that had worked extensively in the US and Asia.

Interesting comments on the sector – Repeating stuff I heard:  India has a rapidly growing middle class that is driving demand for new consumer goods.  Mobile penetration outstrips internet adoption in India.  Every sector is growing in Asia – it’s easier to establish and build a business in this environment than in established economies – everyone rises on a rising tide.  Consumer Internet and Mobile are Hot Sectors for local investors.  Investors in China worry about getting their money out of China.

TAKEAWAYS, in summary:

NZ Angels – we need to: a) network, network, network globally and build relationships for the benefit of our investee companies; and b) find a way to more effectively connect the Senior Executive talent pool in the NZ Expat community to our Companies…KEA can help with this, but it needs to be more exclusive and intimate.

NZ Entrepreneurs – work your investors ruthlessly; mine their networks; get them working on your behalf – writing the cheque is just the start.

Carpe Diem.

OnYa Kiwi Entrepreneurs

2010 has got off to a great start!  The quality that we’re seeing in the opportunities being put in front of us is the best it’s ever been.  So good on you, Kiwi Entrepreneurs and their backers.  Typically what we’re seeing at the moment are:

  • Businesses that are up and running.  Initial product development is done, market entry is mapped out and the core team is in place.
  • Experienced business people.  Increasingly we’re seeing more experienced teams with better balance.  Better balance = people with worldly business experience working in-partnership with great product innovators.  Patience is running out in the investor community for great product people not partnered with real world business experience.
  • More realistic valuations.  I’m obviously biased here but valuations started to run away in 2008/9.  The valuations now being presented are more realistic for the stage of development of companies.  This is particularly so for companies that have been through a few rounds of investment; those that haven’t still have some interesting perspectives on valuation. The most important thing in establishing value is proof.  The more you have the stronger your position.

If you’re looking to raise capital this obviously means that the bar is being raised higher and you will need to make sure you beat the other competition in the market for money.  This means, a business (not idea) with some proof behind and a team with a track record of execution.

Raising capital is still tough but deals are getting done.  That will be the subject of my next post.

Take care.

AngelLink welcomes Life Science Angels Network

Hamilton, New Zealand – 6 November, 2009 – AngelLink, a national angel investment network backing New Zealand high growth technology ventures, with an emphasis on life sciences, engineering and ICT, welcomes the inclusion of the Life Science Angels Network into its structure.  The move is designed to create greater scale and focus in the life sciences angel investment space.

AngelLink’s members include some of the country’s leading biotechnology and high technology investors including Movac, K1W1 and Sparkbox.  AngelLink has also partnered with the NZ Venture Investment Fund (NZVIF) through its Seed Co-Investment Fund.

AngelLink Chairman Chris de Boer says, “Our national network of angel investors and international partnerships provide excellent leverage for high-growth potential start-up companies that are seeking to develop unproven markets or technologies.  Life sciences are a key part of AngelLink’s focus. The inclusion of the Life Science Angels Network helps AngelLink achieve greater scale and expertise in this area.  As a result we’ll see more investment activity in the life sciences space which will benefit the network and the sector in New Zealand.”

The Life Science Angels Network was created by a collaboration between NZBIO, ICE Angels and Auckland Plus to validate the concept of creating a virtual network of angel investors who are interested in investing in life science technology deals.

Andy Hamilton, Director, ICE Angels says, “When it comes to early stage funding there is a case for some sectors, such as life sciences, to have specialisation.  The ongoing viability of the sector depends on its ability to raise funds from a variety of sources and to complete value-creating deals. This access to funding is consistently one of the key constraints identified across the bioeconomy in New Zealand yet, based on international experiences angel investment has the ability to be a key part of the funding solution.”

“Having validated the need for The Life Science Angels Network we readily came to the conclusion that the natural home for the network was actually AngelLink as they already have in place a number of critical partnerships for deal flow in the life sciences space.  As a small country we need to take every opportunity to achieve scale.”

The merger will include all research, contacts and emerging international partnerships, including the Australian Life Science Angel Network, Life Science Angels Inc (USA) and Bansea, Singapore.

NZBIO, the national bioscience industry group, has applauded the transfer to AngelLink.

Chief Executive Bronwyn Dilley says, “AngelLink’s strong focus on life sciences and nationwide coverage will be further strengthened by the inclusion of the Life Science Angels Network.  Angel Investment is an important part of the investment landscape and a strong, focused approach is vital to the success of a mature New Zealand life science industry. It’s great to see AngelLink continue to gain momentum, as the result will be more early stage life science projects are spun out of the lab into the market with benefits to all.”

AngelLink, which was initiated by WaikatoLink, the commercial arm of the University of Waikato, connects investees to the full continuum of funding through its lifecycle from science to market spanning proof of concept, angel investment, early stage venture capital, expansion stage venture capital, and public markets.

AngelLink was launched at a function at NZX in August.  The Minister for Research, Science and Technology, Wayne Mapp was the guest of honour.

At the launch, WaikatoLink Chief Executive Mark Stuart said, “At an industry level there is a real need to make some improvements to generate more economic benefit from life sciences and technology research.  We need to start with the end in mind and bring the market in from the start. We need to encourage a co-ordinated approach and funding models that encourage collaboration rather than competition.  AngelLink represents a step change in early stage company investment by formalising visibility to upcoming investment opportunities to all of the partners across the investment continuum”.

Dr Mapp said, “The highest priority for the New Zealand Government is growth. Future opportunities will depend on innovation and entrepreneurship and much of this comes from fundamental science. AngelLink will connect research and investors with the intent of getting science to the marketplace. Our future prosperity depends on getting this right.”

The first Australasian Life Science Angels Network Meeting today in Queenstown, part of the annual summit organised by the Angel Association of New Zealand, is the setting for the first meeting between AngelLink, the Australian Life Science Angel Network and Bansea, Singapore.

For more on AngelLink see http://www.angellink.co.nz

Tindall becomes NZ’s first ‘Arch Angel’

Sir Stephen Tindall has been appointed the first ever New Zealand Arch Angel at the Angel Association of New Zealand’s second Angel Summit in Queenstown on Friday.

Angel Association Chair Andrew Hamilton said the award of Arch Angel honours Sir Stephen’s extraordinary contribution to the angel investing industry.

“Sir Stephen Tindall has invested over $150 million in seed and venture capital companies – both directly and as a fund-of-funds. He and his family have invested in over 100 New Zealand companies.

“His passion is to assist young entrepreneurs and he has invested in a variety of sectors including biotech, clean tech, IT and design led companies. He wants to see New Zealand develop as a leader in the ‘knowledge economy’, and to help create a culture of making New Zealand ‘cash flow positive’ in international goods and services trade.

“Sir Stephen’s wider contribution to New Zealand has been exceptional , including his charity work, founding Kea – the expat organisation that now has over 25,000 members worldwide, focusing on climate change, or actively investing into emerging Kiwi companies that are now taking on world markets. His contribution is quite extraordinary in a world-setting and we are extremely grateful to Stephen for his continued support and investment.”

Houston might we have a problem?

Over the last couple of weeks our deal flow has gone through the roof.  In the normal course of events we receive about 100 investment proposals a year.  They range from “I had an idea in the shower this morning” through to “well worked up businesses seeded with personal and / or family money”.  The thing that’s different at the moment is that we’re seeing:

  • more deals,
  • better worked-up – with money behind them,
  • all looking for funding of between $1m and $5m, and
  • backed by great people

This points to a giant hole in the early stage New Zealand capital markets – a complete dearth of options for young New Zealand companies to go to for second stage funding.  I say second stage because by and large the early stage, seed investment market is operating OK.  It’s the second stage that looks increasingly broken.  And here’s the rub, if we don’t fix the second stage the first stage of the market will run out of steam as well!

What’s this mean? For ENTREPRENEURS:

  • make sure you have an excellent story regarding where your follow-on funding is coming from; and / or
  • Bootstrap – find ways to make revenue = always a good thing!

For INVESTORS:

  • Time to get our act together!

New angel investment network targets life sciences

Wellington, Tuesday 25 August, 2009 – A national angel investment network has been launched to back New Zealand high growth technology ventures, with an emphasis on life sciences, engineering and ICT.  AngelLink aims to bring together active angel investors with a constant stream of high quality IP based deal flow, to facilitate early stage investment.

AngelLink’s members include some of the country’s leading biotechnology and high technology investors: Neville Jordan, a prominent science, technology and engineering investor; angel investment company Movac, an early investor in TradeMe; investment fund K1W1; and Sparkbox, an ICT angel investor.

AngelLink has partnered with the NZ Venture Investment Fund (NZVIF) through its Seed Co-Investment Fund.  NZVIF will contribute up to $4 million which will be matched AngelLink. Follow on investments from the angel investors could also substantially increase the investment over the initial $8 million target.

AngelLink Chairman Chris de Boer says, “Angel investors are a vital source of early-stage financing for high-growth science and technology companies.  We’re launching AngelLink at a time when access to capital is more important than ever.  We can make a very real contribution to New Zealand by unleashing economic potential from high quality science and technology research.”

AngelLink’s formation was initiated by WaikatoLink, the commercial arm of the University of Waikato, which will have a role managing the network and screening, monitoring and incubating ventures.

WaikatoLink Chief Executive Mark Stuart says, “We need to take an NZ Inc approach if we want to achieve the scale required for the innovation ecosystem to deliver what it is truly capable of and to drive New Zealand’s success.  AngelLink’s collaborative investment approach will draw on the success we’ve had with Unicom, the university commercialisation consortium we initiated for collaborative investing at the earlier pre seed investment stage. National collaboration is the best way to ensure the highest chance of success for ventures.”

AngelLink’s nationwide network and collaborative investment approach will allow a range of investors to participate in investment.

Greg Sitters from Sparkbox says, “AngelLink and Unicom provide deal flow for participating members.  These initiatives represent one of the most organised and developed technology transfer collaborations between education, science and the investment industry.  In practise we will see better structured, better organised, investment ready opportunities.  We will be able to work quicker to turn around our investment decisions and support the company.”

“The benefits of AngelLink’s intentional co-investment strategy are clear cut.  We are 10 – 20, 000 miles away from our markets.  We need to get close to our markets as quickly as possible, and we’ll be able to do that by drawing on the experience of the group and tapping into existing networks.  If we can shorten a venture’s time to market by 2 years through this collaborative approach it may be the difference required to achieve market success.  We now plan on making at least 75% of our investments in collaboration with other investors to utilise capabilities of each group in an investment.”

David Beard a partner at Movac, another AngelLink member, reinforces this message, “AngelLink encourages co-investment among investment parties for the betterment of New Zealand and its structure fosters and supports this process. AngelLink represents the next step forward in angel investment as it exposes investors to more deal flow and better value propositions. Our investments stand the best chance to succeed when they have a good group around them to help them succeed – and this is not just about money, it’s about skills, experience and networks.  Each party brings something unique to the table. Our last 4 deals were co-investments and we envisage AngelLink will facilitate better and across a wider set of investors than we currently deal with.”

To ensure a vibrant angel investment network, investors need to see regular high quality opportunities. For each investment one of the core experienced investors will act as lead creating opportunities for co-investment with a larger group.

Deal flow will come from a variety of sources across New Zealand including research institutions, universities, incubators, industry networks and professional networks, in order to offer angel members a diverse range of opportunities for investment.

“AngelLink’s strong focus on life sciences and nationwide coverage will see more early stage life science projects spun out of the lab into the market with benefits to all.  Angel Investment is an important part of the investment landscape and one which NZBIO believes will be vital to the success of a mature New Zealand life science industry. We applaud the initiative and will be lending support through our network.” says Bronwyn Dilley, Chief Executive, NZBIO.

Companies seeking investment will be screened and taken through a proven stage gate decision process to validate their suitability for investment.  The suitable investees will be mentored to prepare them for due diligence and presentation to potential angel investors. AngelLink’s rigorous pre investment due diligence will be matched by close engagement post investment.  Each venture will be monitored and mentored to ensure visibility and planning for future investment rounds and syndication.  WaikatoLink, with a strong track record in due diligence and investment performance, will play a key role in this process.

AngelLink will follow on from other collaborations to support commercialisation such as Unicom, the university commercialisation consortium comprising WaikatoLink, AUT University, Lincoln University and Canterbury University, which is supported by government pre seed funding.

Dr. Nigel Johnson, Director Research and Innovation, University of Canterbury says, “The Unicom collaboration has demonstrated value through pooling resources, networks, best practise, IP and experience across the group. Visibility at an early stage allows us to combine IP from the universities, if appropriate, and to tap into the skills of the group for commercialisation. This means we’re not duplicating effort and giving each venture the best chance of success. AngelLink continues this collaborative approach to investment.”

Dr. Kevin Pryor, Chief Executive, AUT Enterprises adds, “New Zealand is small and we have limited financial capital, human capital, and limited access to mentor programmes and in market advisors. The scale and increased activity we’ve achieved with Unicom has helped us attract a top calibre independent investment committee including Bill Day, Hon Ruth Richardson, and Professor Mark Ahn.  This has lifted the level and quality of business planning and commercialisation processes and ensures ventures are prepared for angel investment through AngelLink. “

AngelLink aims to connect investees to the full continuum of funding through its lifecycle from science to market spanning proof of concept, angel investment, early stage venture capital, expansion stage venture capital, and public markets.

“At an industry level there is a real need to make some improvements to generate more economic benefit from life sciences and technology research.  We need to start with the end in mind and bring the market in from the start. We need to encourage a co-ordinated approach and funding models that encourage collaboration rather than competition.  AngelLink represents a step change in early stage company investment by formalising visibility to upcoming investment opportunities to all of the partners across the investment continuum”, says Mark Stuart.
Hon Dr Wayne Mapp, Minister for Research, Science and Technology adds, “The highest priority for the New Zealand Government is growth. Future opportunities will depend on innovation and entrepreneurship and much of this comes from fundamental science. AngelLink will connect research and investors with the intent of getting science to the marketplace. Our future prosperity depends on getting this right.”
– ENDS –

Free Book: Invest to Exit – Tom McKaskill

Tom McKaskill is a very successful business entrepreneur and well known and respected author on the subject of building businesses for exits.  I’ve known Tom for a couple of years now and enjoyed his significant insights on the subject of Angel Investing and exit planning.  Tom has written several books which are all excellent essential reads for entrepreneurs and investors alike.  I’d strongly recommend that you take a look at them.  The two he’s making available free of charge are!

  1. The Investor Pitch – see http://www.tommckaskill.com/art_Investor_Pitch.pdf; and
  2. Invest to Exit - A pragmatic strategy for Angel and Venture Capital Investors.  Investors in early stage ventures need to focus on strategic exits if they are to achieve a high return on their investments. This book explains the characteristics of strategic value, how the investor should negotiate the investment and how they should manage the process to a strategic trade sale. The book includes a very detailed discussion on the problems of high growth ventures, the unrealistic expectations associated with IPOs and the advantages of investing in strategic value ventures. See http://www.wholesaleinvestor.com.au/public_panel/news_detail.php?id_NEW=44 or http://www.avcal.com.au/research/australian/4 or http://nzangels.com/

ENJOY!

How to address the recession

The global recession is starting to bight hard.  But recessions present great opportunities for innovation.  Anecdotally and somewhat surprisingly (for us) the companies we’ve invested in have been experiencing an uptick in inquires over the last 6-months.  This appears to have been stimulated by a far greater willingness from businesses to consider change.  Anything that can help reduce costs or stimulate demand are now being more willingly considered.  So, that’s good.

However, capital markets are drying up and early stage investors need to consider long and hard the wisdom of investing in start-ups that have large on-going capital requirements – in this environment.  The view we’re taking at the moment is to “shy away” from opportunities that we see will need more than $5m in capital to commercialise them.  The reason being that the risks associated in raising this capital have increased significantly over the last 6-months.  We want to see businesses that could be realistically bought to market without requiring a big hit from a large US Venture Capital firm.

The path-to-break-even is also extremely important in this environment.  Cash is king and demonstrating a path to early cash flow generation will be a real plus in the eyes of any early stage investor.  To manage risk we are look long and hard at whether companies have options for generating enough early stage sales to become self-sufficient (maybe not hitting the high growth points we earlier would have hoped for) but providing the opportunity to ride out the storm and be positioned for growth when the world starts to right itself.  FYI, my current view is that we’re in this for atleast another three years….i hope i’m wrong and it’s shorter.

In summary three things to think about:

  1. How does your business / opportunity provide value, to who, in a recession?
  2. Be conservative on your overall cash requirements – don’t set a plan to raise the same amount of money as Facebook or Twitter?
  3. Plot a potential path to break-even….ASAP

Creating value

The inaugural angel association conference is scheduled for next week.  This conference is a great opportunity for angel investors to get together, network and share war stories.  I’ve been asked to run a session at this conference on the subject of “creating value in companies”, so i thought i’d take the opportunity to: a) get organised; and b) share some thoughts.

So here goes…”Building value in investee companies…an investors perspectives“.

Three key things to think about:

Focus early on the things you believe will create value,

Actively avoid the things that could destroy value, and

Actively manage your on-going funding needs

Things that add value

Building a business and managing your investment funding is about identifying and doing the things that create value in a business.  So, if we did an initial investment at say a valuation of $2m, we need to ask and answer the question “what do we need to do to grow the value to say $6m”.  From an investment point of view the valuation should be increasing significantly at each subsequent investment round.  So what’s the justification for value increase?  Well, it kinda depends on the idea and the industry that the business is operating in, but the things i look for are:

  1. We’ve nailed the technology / product - note i use “we” because when Movac invests we become a team and its our job to help ensure these objectives get achieved…moving on…the first investment stage should ABSOLUTELY sort out the key technology or product risks and establish that the company can produce its widgets and ideally knows how to scale production up.  Generally i take this as a given – KIWI’s are bloody good at this.
  2. We’ve protected our technology position - this is not relevant to all businesses, but patents can have significant value.  They provide a window of opportunity and protection for executing a new idea.  They also provide a basis for licensing deals. But you need to go beyond simply filing a PCT (i don’t rate PCTs without the backup) and do the real work…establish freedom to operate and commence the process of filing in your targeted market geography.  This means finding and spending the money on a good patent lawyer.
  3. We’ve passed or progressed any major regulatory hurdles - again not relevant to all businesses but fundamentally important to BioTech businesses and any physical product that is likely to run into regulatory hurdles – domestically or internationally.  Be aware that the regulatory issues in Europe are somewhat of a mind field for young NZ businesses and this will be an area that you need help with.
  4. We’ve assembled market proof - this is the stuff that, in my experience, KIWI companies are kinda crap at (gross generalisation, I know).  The strongest position that you can be in, in this regard, is that you are trading product; and/ or have signed distribution agreements; and/ or have an established pipeline of opportunities.  Leverage the support that NZTE and organisations like KEA can provide to this process.  You need to get offshore, meet people and do deals.  You need to figure out how to sell your widget globally.
  5. We know how to scale up - we’ve addressed how to scale our business, particularly manufacturing and distribution, we’ve worked out the issues associated with manufacturing at scale, we understand the support issues, we’ve worked through any compliance related issues.
  6. We’ve got a great team that’s positioned to execute - this one can not be under-rated and the worst assumption that we see made is when entrepreneurs believe they have all the skills and experience – in some cases they may have the skills but not the experience.  Having people that have been there before is absolutely invaluable and earns a BIG TICK from us.  An execution team, in our view will comprise:
    • A sales guy / gal - the person who can get out there and sell / market the sh*^te out of the product.
    • A product gal / guy - the person who knows how to make the product sing and dance.
    • A numbers guy / gal - the person who understands how the business operates in a spreadsheet.  Can articulate the implications of key decisions.
    • A strategic / management gal / guy - the person who can define and articulate long range strategy and who can recruit and build teams.
  7. We’ve got good governance in place - ideally we’ve got a functioning board with some wise, experienced heads, one or two independents directors (who have no or minor shareholding stakes) and a robust Shareholder’s agreement.  Shareholder agreements are crucial to enable effective decision making around subsequent stages of investment.

Things that destroy value

Apart from failing to achieve the things outlined above, the things that can destroy value in a business are typically the big time wasters such as:

  1. Unaligned shareholders + poor governance - a shareholder and / or director group that is not aligned around the goals for their investment (particularly timeframes for returns), confused about their roles or in openly hostile confrontation are sole destroying for a start-up.  From an investment point of view you can smell these issues a mile away.  The tend to create a corrosive culture around a business and result in lots of wasted time and distraction.  For this reason – treat you shareholders and investors well; communicate openly and regularly; work at maintaining alignment but don’t engage them in operational aspects of the business.
  2. Entrepreneurs who do not listen - the transition from entrepreneur to manager of a global $10m plus business should not be underestimated.  Entrenched entrepreneurs who are not willing to adapt their role as the business develops can be and generally are major impediments to growth.  Working through these issues consumes a lot of time and is highly demotivating for all parties concerned.
  3. Badly diluted founders - founders tend to be emotionally attached to their shareholding percentage and this can have a major impact on their on-going motivation in the business.  The tricky exercise here is managing the risk / reward equation throughout the on-going investment stages of the business.
  4. Failing to manage the investment pathway - early stage companies always run out of money.  You need to stay on top of the businesses on-going requirements for capital and actively manage where you expect this to come from.  Avoid the assumption that the initial group of shareholders will keep investing for ever; regardless of how the company is doing you can not anticipate your investor groups wider drivers and limitation on funds.  See further comments below.

Managing the investment pathway

The investment pathway is something often ignored in the business proposals that we see.  Essentially this is actively planning the capital (investment) requirements for the business and putting a plan in place to:

  1. Achieve the investment objectives (normally the same as the business objectives); and
  2. Procure the funds at the target valuation

Many early stage investors and founding entrepreneurs often ignore the impact of potential dilution rounds on their projected returns – this can become a real stumbling block to obtaining agreement on subsequent rounds of investment.  So, the better prepared that everyone is for this the better.

The capital investment plan looks at:

  1. The staging of capital - how much money is needed at each stage (each stage should provide for at least 18-months business development);
  2. The objectives to be achieved for each stage - these are the things that, if achieved, will improve the value of the business; and
  3. Where we expect the capital to come from - you  need to start your understanding and research on this early.  Most venture capital companies are upfront with their investment criteria, so you should be able to identify potential sources of capital.  The other things to explore are: what value can they add outside of money; how far through their funds they are; and their timing needs for exit – these factors will help identify the playing field for potential funding.

You need to start the dating game with potential investors very early in the process.  You should plan a “relationship development” campaign in exactly the same way you would with a potential large client.   Don’t leave it to the last minute to start this process.

If you’ve managed to do all these things, then your business is well positioned for growth and sucess – even in the current climate.

Good luck

QED (-;

Stephen Tindall discusses Seed Investment, Philanthropy and Sustainability

I stumbled on this interview today, hosted by Paul Callaghan of The MacDiarmid Institute with Stephen Tindall.  In this interview Stephen discusses a range of topics including his passion for early stage investment, his work in philanthropy and sustainability.  Much of what he has to say resonates personally with me.

Enjoy…(FYI: set aside 20 minutes, to get through it)

Click here.

Follow

Get every new post delivered to your Inbox.

Join 140 other followers